fluticasone furoate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ARNUITY ELLIPTA fluticasone furoate 100 microgram powder for inhalation dry powder inhaler
AUST R: 231095
Active ingredients:
fluticasone furoate

Dosage form:
Inhalation, powder for

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

From
17 Jul 2026
to
21 Aug 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
Another strength is available.